Centene Corporation
Healthcare services
Based in DC
🤖
AI Overview
With $1.1M in lobbying spend across 17 quarterly filings, Centene Corporation is a significant lobbying presence. Their lobbying covers 5 issue areas. Active from 2021 to 2024.
$1.1M
Total Spend
4
Years Active
1
Firms Hired
10
Lobbyists Deployed
5
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $280K |
| 2022 | $280K |
| 2023 | $280K |
| 2024 | $260K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Budget/Appropriations, Insurance, Taxation
- •Advise on legislative outlook with respect to health care issues, particularly related the ACA/marketplace, Medicaid and medicare. Assist with outreach to Congressional offices.
- •Advise on legislative outlook with respect to health care issues, particularly related to ACA/marketplace, Medicaid and Medicare. Assist with outreach to Congressional offices.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
American Academy of Pediatric Dentistry
$1.1M total spend
America's Health Insurance Plans INC (Ahip)
$96.4M total spend
Guardian Life Insurance Company of America
$16.7M total spend
National Association of Benefits and Insurance Professionals
$8.6M total spend
Blood Cancer United (FKA the Leukemia & Lymphoma Society)
$6.8M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.